Pruebas inmunodiagnosticas

Solo disponible en BuenasTareas
  • Páginas : 6 (1363 palabras )
  • Descarga(s) : 0
  • Publicado : 29 de agosto de 2012
Leer documento completo
Vista previa del texto
1. tema de revision es Life Quality Impairment Caused by Hookworm-Related Cutaneous Larva Migrant in Resource-Poor Communities in Manaus, Brazil
2. para hacer la consulta ingrese a pudmed . escribí el nombre de mi parasito en la casilla de search le di click
3. y me resulto votando artículos sobre el ancylostoma caninum y ancylostma brasiliense
4, total de búsqueda de artículos fueron 515. escogí el tema Life Quality Impairment Caused by Hookworm-Related Cutaneous Larva Migrans in Resource-Poor Communities in Manaus, Brazil porque explica la tasa epidemiológica , habla sobre las larvas migran , explicación la tasa morbilidad nos guía para hacer su trópico o clima en donde predomina o población

Carlos Andrés ramos prieto
09182103

Ancylostma brazilense
Life QualityImpairment Caused by Hookworm-Related Cutaneous Larva Migrans in Resource-Poor Communities in Manaus, Brazil
Angela Schuster,1,* Hannah Lesshafft,1 Sinésio Talhari,2 Silás Guedes de Oliveira,2 Ralf Ignatius,3 and Hermann Feldmeier1
Author information ► Article notes ► Copyright and License information ►
Abstract
Background
Hookworm-related cutaneous larva migrans (CLM) is a common but neglectedtropical skin disease caused by the migration of animal hookworm larvae in the epidermis. The disease causes intense pruritus and is associated with important morbidity. The extent to which CLM impairs skin disease-associated life quality has never been studied.
Methods
A modified version of the Dermatology Life Quality Index (mDLQI) was used to determine skin disease-associated life quality in91 adult and child patients with CLM, living in resource-poor communities in Manaus, Brazil. Symptoms and signs were documented and skin disease-associated life quality was semi-quantitatively assessed using mDLQI scores. The assessment was repeated two and four weeks after treatment with ivermectin.
Results
Ninety-one point five percent of the study participants showed a considerable reductionof skin disease-associated life quality at the time of diagnosis. The degree of impairment correlated with the intensity of infection (rho=0.76, p<0.001), the number of body areas affected (rho=0.30; p=0.004), and the presence of lesions on visible areas of the skin (p=0.002). Intense pruritus, sleep disturbance (due to itching) and the feeling of shame were the most frequent skindisease-associated life quality restrictions (reported by 93.4%, 73.6%, and 64.8% of the patients, respectively). No differences were observed in skin disease-associated life quality restriction between boys and girls or men and women. Two weeks after treatment with ivermectin, skin disease-associated life quality improved significantly. After four weeks, 73.3% of the patients considered theirdisease-associated life quality to have returned to normal.
Conclusions
CLM significantly impaired the skin disease-associated life quality in child and adult patients living in urban slums in North Brazil. After treatment with ivermectin, life quality normalised rapidly.
-Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans.
Heukelbach J, Feldmeier H.
SourceDepartment of Community Health, School of Medicine, Federal University of Ceará, Brazil.
Abstract
Hookworm-related cutaneous larva migrans is caused by the migration of animal hookworm larvae in the human skin. The disease mainly occurs in resource-poor communities in the developing world, but it is also reported sporadically in high-income countries and in tourists who have visited the tropics.Diagnosis is made clinically in the presence of a linear serpiginous track moving forward in the skin, associated with itching and a history of exposure. Itching is typically very intense and can prevent patients from sleeping. Bacterial superinfection occurs as a result of scratching. Treatment is based on oral drugs (albendazole or ivermectin) or the topical application of tiabendazole. To control...
tracking img